• Non ci sono risultati.

Methadone Accounted for 23% of Opioid OD Deaths in 2014 — CDC report: Higher use of the prescription drug found among Medicaid population

N/A
N/A
Protected

Academic year: 2021

Condividi "Methadone Accounted for 23% of Opioid OD Deaths in 2014 — CDC report: Higher use of the prescription drug found among Medicaid population"

Copied!
2
0
0

Testo completo

(1)

Methadone Accounted for 23% of Opioid OD Deaths in 2014

— CDC report: Higher use of the prescription drug found among Medicaid population

Pain Management

Methadone-related overdoses accounted for nearly one in four deaths related to prescription opioids in 2014, despite a recent decline in drug overdose deaths involving methadone, said researchers from the Centers for Disease Control and Prevention.

Overall, the rate of methadone-overdose deaths increased 600% from 1999 to 2006 (from 0.3 persons per 100,000 to 1.8 per 100,000) before declining to 1.1 per 100,000 in 2014, reported Mark Faul, PhD, and colleagues.

While the drug accounted for only 1% of all opioid prescriptions, methadone- related deaths were responsible for 22.9% of opioid-related deaths in 2014, the authors wrote in the Morbidity and Mortality Weekly Report,

In an attempt to explain this decline in methadone-related mortality, the

researchers noted that the FDA issued a Public Health Advisory in December 2006 that linked methadone to reports of respiratory depression and cardiac

arrhythmias, among other serious side effects. Moreover, in January 2008, there was a voluntary manufacturer restriction that limited the distribution of the 40 mg formulation of methadone.

Faul and colleagues also examined methadone prescription by insurance type and found that prescriptions for methadone accounted for a higher portion of all

by Molly Walker

Staff Writer, MedPage Today March 30, 2017

(2)

opioid prescriptions in the Medicaid population compared with the commercially insured population -- 0.85% weighted versus 1.1%, respectively.

Further, the team investigated the role that Medicaid preferred-drug-list (PDL) policies played in these potential deaths, examining the rates of fatal and nonfatal methadone overdose among Medicaid enrollees in two states where methadone was listed as a preferred drug on its PDL (Florida and North Carolina) versus one state where methadone was not listed on the PDL (South Carolina). Not

surprisingly, overdose rates were significantly lower in South Carolina than in both North Carolina and Florida:

"Given that methadone prescribing rates are higher among persons enrolled in Medicaid, strategies to reduce methadone prescribing among persons in this

population might further reduce injuries and deaths from methadone," the authors wrote. "If confirmed by additional studies, other states could consider Medicaid drug utilization management strategies such as PDL placement among other evidence-based strategies."

The researchers examined three sources for these data: Drug overdose deaths and mortality rates were calculated through National Vital Statistics System Multiple Cause of Death mortality files and bridged U.S. Census data for 1999-2014. Truven Health's MarketScan database for commercial claims and encounters was

examined and compared with information from Medicaid multistate databases for 2014. Finally, Health Care Utilization Project data were examined from three states to determine whether a state's policy was associated with higher methadone morbidity and mortality rates.

Florida: 1.75 per 100,000 persons, 95% CI 1.57-1.94

.

North Carolina: 1.67 per 100,000 persons, 95% CI 1.35-1.98

.

South Carolina: 0.81, 95% CI 0.65-0.96

.

Primary Source

Morbidity and Mortality Weekly Report

Source Reference: Faul M, et al "Methadone prescribing and overdose and the association with Medicaid preferred drug list policies -- United States, 2007-2014" Morb Mortal Wkly Rep 2017; 66 (12):320-323.

Riferimenti

Documenti correlati

The resulting report, Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use, states that a sustained,

methadone.* CDC analyzed state mortality and health care data and preferred drug list (PDL) policies to 1) compare the percentage of deaths involving methadone with the rate

● For drug overdose deaths involving synthetic opioids other than methadone, which include drugs such as fentanyl and tramadol, the percentage increased from 8% in 2010 to 18% in

associated with drug overdose deaths. During 2014, a total of 47,055 drug overdose deaths occurred in the United States, representing a 1­year

Patients are at risk for heart rhythm or heart rate abnormalities or respiratory depression with increased dosing..

Among others, these are the costs that the health systems in consumer countries would have to pay for treating dependent users and problematic drug consumers, the productivity

CDC is working to reverse the prescription drug overdose epidemic by focusing on three areas that are both central to the CDC mission and complementary to the work of our

Table 4.72 Blood-borne viruses: Hepatitis B vaccination status by prison drug use category 98 Table 4.73 Blood-borne viruses: Hepatitis B vaccination location (among those who